Tina S. Nova Bennett Ph.D.
|Age||Total Calculated Compensation||This person is connected to 55 board members in 6 different organizations across 12 different industries.|
See Board Relationships
Dr. Tina S. Nova Bennett, Ph.D., serves as Chief Executive Officer and President at Molecular Stethoscope, Inc. since October 2015. Dr. Nova Bennett served as Senior Vice President of Oncology Business and General Manager of Oncology Business at Illumina Inc. since July 14, 2014 until August 2015. Dr. Nova Bennett served as a Consultant of Adamis Pharmaceuticals Corporation. She founded Genoptix Inc. in 2000 and served as its Chief Executive Officer since March 2000 ...
1811 Aston AvenuePhone: 760-268-6200
Carlsbad, California 92008
Board Members Memberships*
University of California, Riverside
University of California, Irvine
NYU Elaine A. and Kenneth G. Langone Medical Center
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|Christopher James O'Connell||Chief Executive Officer, President and Director|
|Michael R. McMullen||Chief Executive Officer, President and Director |
Agilent Technologies, Inc.
|Robert F. Friel||Chairman, Chief Executive Officer and President|
|Heinz-Jurgen Bertram Ph.D.||Chairman of Executive Board, Chief Executive Officer, Labour Director and President of Flavor & Nutrition Worldwide|
|Gunupati Venkateswara Prasad B.Sc. (Chem. Eng.), M.S. (Indl. Admn.)||Co-Chairman, Chief Executive Officer, Managing Director, Member of the Management Council, Member of Management Committee, Member of Stakeholders' Relationship Committee, Member of Investment Committee and Member of Corporate Social Responsibility Committee|
Dr. Reddy's Laboratories Limited
|8.3M||Compensation as of Fiscal Year 2015.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.